New Cryoport Partnerships Featured in Biopharma-Reporter, Contract Pharma, and

October 15, 2019

“The past year has seen Cryoport establish multiple collaborations and expansions of its offering,” says a new article in BioPharma-Reporter, “due to the booming cell and gene therapy space and the rising number of temperature-sensitive regenerative medicine in development.”

Cryoport recently signed a three-year partnership with Adaptimmune in order to help optimize manufacturing and supply operations ahead of a planned commercialization, as well as reduce “vein-to-vein" time for patients in clinical trials.  

This year, Cryoport has also established partnerships with CelularityEversana, and Vineti; the company acquired Houston-based biostorage services provider Cryogene in May.  

The promising new partnerships have contributed to an exciting 2019 for Cryoport, which includes a record-breaking Q2 earnings report and the launch of the first-ever line of shippers specifically created for regenerative medicine therapies. 

Read the BioPharma-Reporter article  
Read the Contract Pharma article
Read the article

Questions or comments? We welcome your feedback!

Email Us

Tags: Temperature Controlled Logistics, cold chain shipping, transportation, Cryoport News, Biopharma Industry News

Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC